thromboxanes has been researched along with Cardiometabolic Syndrome in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (40.00) | 29.6817 |
| 2010's | 3 (60.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Dasilva, G; Medina, I | 1 |
| Butcher, JT; Chantler, PD; Frisbee, JC; Frisbee, SJ; Goodwill, AG; Wu, F | 1 |
| Goloborodova, IV; Lavrenova, NIu; Sokolov, EI | 1 |
| Gil'mutdinova, LT; Syrtlanova, ER | 1 |
| Gil'mutdinova, LT; Sharapova, SP; Syrtlanova, ER | 1 |
2 review(s) available for thromboxanes and Cardiometabolic Syndrome
| Article | Year |
|---|---|
Lipidomic methodologies for biomarkers of chronic inflammation in nutritional research: ω-3 and ω-6 lipid mediators.
Topics: Biomarkers; Cardiovascular Diseases; Chromatography, Liquid; Diet; Dietary Fats; Fatty Acids, Omega-3; Fatty Acids, Omega-6; Humans; Inflammation; Isoprostanes; Lipid Peroxides; Lipidomics; Mass Spectrometry; Metabolic Syndrome; Obesity; Prostaglandins; Thromboxanes | 2019 |
Microvascular perfusion heterogeneity contributes to peripheral vascular disease in metabolic syndrome.
Topics: Animals; Humans; Metabolic Syndrome; Microcirculation; Muscle, Skeletal; Peripheral Vascular Diseases; Thromboxanes | 2016 |
3 other study(ies) available for thromboxanes and Cardiometabolic Syndrome
| Article | Year |
|---|---|
[The role of prostaglandins in platelet aggregation in metabolic syndrome].
Topics: Adenosine Diphosphate; Arachidonic Acid; Blood Platelets; Collagen; Cyclic AMP; Epinephrine; Epoprostenol; Hemostasis; Humans; In Vitro Techniques; Metabolic Syndrome; Platelet Aggregation; Prostaglandin Endoperoxides; Prostaglandins; Thromboxanes; von Willebrand Factor | 2010 |
[The use of moxonidine in patients with essential hypertension combined with metabolic syndrome].
Topics: Adult; Antihypertensive Agents; Blood Glucose; Humans; Hypertension; Imidazoles; Insulin; Kinins; Male; Metabolic Syndrome; Middle Aged; Plasma Kallikrein; Thromboxanes | 2003 |
[Effect of fosinopril on some parameters of endothelial function in patients with metabolic syndrome].
Topics: Adult; Antihypertensive Agents; Endothelium, Vascular; Female; Fosinopril; Humans; Kallikrein-Kinin System; Male; Metabolic Syndrome; Middle Aged; Prostaglandins I; Severity of Illness Index; Thromboxanes; Vasodilation | 2005 |